19-51630108-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_003830.4(SIGLEC5):āc.146C>Gā(p.Ser49Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000087 ( 0 hom., cov: 5)
Exomes š: 0.000019 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SIGLEC5
NM_003830.4 missense
NM_003830.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: -3.38
Genes affected
SIGLEC5 (HGNC:10874): (sialic acid binding Ig like lectin 5) This gene encodes a member of the sialic acid-binding immunoglobulin-like lectin (Siglec) family. These cell surface lectins are characterized by structural motifs in the immunoglobulin (Ig)-like domains and sialic acid recognition sites in the first Ig V set domain. The encoded protein is a member of the CD33-related subset of Siglecs and inhibits the activation of several cell types including monocytes, macrophages and neutrophils. Binding of group B Streptococcus (GBS) to the encoded protein plays a role in GBS immune evasion. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0966571).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIGLEC5 | NM_003830.4 | c.146C>G | p.Ser49Cys | missense_variant | 2/9 | ENST00000683636.1 | NP_003821.1 | |
SIGLEC5 | NM_001384708.1 | c.146C>G | p.Ser49Cys | missense_variant | 2/8 | NP_001371637.1 | ||
SIGLEC5 | NM_001384709.1 | c.146C>G | p.Ser49Cys | missense_variant | 2/8 | NP_001371638.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIGLEC5 | ENST00000683636.1 | c.146C>G | p.Ser49Cys | missense_variant | 2/9 | NM_003830.4 | ENSP00000507738 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 3AN: 34456Hom.: 0 Cov.: 5 FAILED QC
GnomAD3 genomes
AF:
AC:
3
AN:
34456
Hom.:
Cov.:
5
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000983 AC: 7AN: 71200Hom.: 0 AF XY: 0.000137 AC XY: 5AN XY: 36392
GnomAD3 exomes
AF:
AC:
7
AN:
71200
Hom.:
AF XY:
AC XY:
5
AN XY:
36392
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000189 AC: 10AN: 528842Hom.: 0 Cov.: 6 AF XY: 0.0000254 AC XY: 7AN XY: 275774
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
10
AN:
528842
Hom.:
Cov.:
6
AF XY:
AC XY:
7
AN XY:
275774
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000871 AC: 3AN: 34456Hom.: 0 Cov.: 5 AF XY: 0.00 AC XY: 0AN XY: 15150
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
3
AN:
34456
Hom.:
Cov.:
5
AF XY:
AC XY:
0
AN XY:
15150
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.146C>G (p.S49C) alteration is located in exon 2 (coding exon 2) of the SIGLEC5 gene. This alteration results from a C to G substitution at nucleotide position 146, causing the serine (S) at amino acid position 49 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D
REVEL
Benign
Sift
Benign
.;T
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MutPred
Gain of catalytic residue at W50 (P = 0.013);Gain of catalytic residue at W50 (P = 0.013);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at